Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Gufic BioSciences Ltd.
Swot
Gufic BioSciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Gufic BioSciences Ltd. has 9 Strengths, 10 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(9)
Weakness
(10)
Opportunity
(4)
Threats
(0)
Others
(3)
MACD Crossover Above Signal Line
Benjamin Graham Value Screen
Mid-range Performer (DVM)
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Companies with Zero Promoter Pledge
MACD crossed above signal line previous end of day
Volume Shockers
PE higher than Industry PE
High PE (PE > 40)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining profits every quarter for the past 2 quarters
Weak Momentum: Price below Short, Medium and Long Term Averages
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Bullish or Bearish Candlestick Strength - Indices
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
